368 related articles for article (PubMed ID: 29099939)
1. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Palermo A; Santonati A; Tabacco G; Bosco D; Spada A; Pedone C; Raggiunti B; Doris T; Maggi D; Grimaldi F; Manfrini S; Vescini F
J Clin Endocrinol Metab; 2018 Jan; 103(1):271-280. PubMed ID: 29099939
[TBL] [Abstract][Full Text] [Related]
2. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
[TBL] [Abstract][Full Text] [Related]
3. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy.
Tabacco G; Tay YD; Cusano NE; Williams J; Omeragic B; Majeed R; Almonte MG; Rubin MR; Bilezikian JP
J Clin Endocrinol Metab; 2019 Jul; 104(7):2748-2756. PubMed ID: 30776291
[TBL] [Abstract][Full Text] [Related]
6. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
Khan AA; Rejnmark L; Rubin M; Schwarz P; Vokes T; Clarke B; Ahmed I; Hofbauer L; Marcocci C; Pagotto U; Palermo A; Eriksen E; Brod M; Markova D; Smith A; Pihl S; Mourya S; Karpf DB; Shu AD
J Clin Endocrinol Metab; 2022 Jan; 107(1):e372-e385. PubMed ID: 34347093
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
Liu XX; Zhu XY; Mei GH
Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.
Tay YD; Tabacco G; Cusano NE; Williams J; Omeragic B; Majeed R; Gomez Almonte M; Bilezikian JP; Rubin MR
J Clin Endocrinol Metab; 2019 Nov; 104(11):5601-5610. PubMed ID: 31310310
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism.
Vokes TJ; Mannstadt M; Levine MA; Clarke BL; Lakatos P; Chen K; Piccolo R; Krasner A; Shoback DM; Bilezikian JP
J Clin Endocrinol Metab; 2018 Feb; 103(2):722-731. PubMed ID: 29099947
[TBL] [Abstract][Full Text] [Related]
10. Therapy of hypoparathyroidism with intact parathyroid hormone.
Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
[TBL] [Abstract][Full Text] [Related]
11. Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.
Cusano NE; Rubin MR; McMahon DJ; Zhang C; Ives R; Tulley A; Sliney J; Cremers SC; Bilezikian JP
J Clin Endocrinol Metab; 2013 Jan; 98(1):137-44. PubMed ID: 23162103
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
[TBL] [Abstract][Full Text] [Related]
13. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
[TBL] [Abstract][Full Text] [Related]
14. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA; Rubin MR; Schwarz P; Vokes T; Shoback DM; Gagnon C; Palermo A; Marcocci C; Clarke BL; Abbott LG; Hofbauer LC; Kohlmeier L; Pihl S; An X; Eng WF; Smith AR; Ukena J; Sibley CT; Shu AD; Rejnmark L
J Bone Miner Res; 2023 Jan; 38(1):14-25. PubMed ID: 36271471
[TBL] [Abstract][Full Text] [Related]
16. Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.
Winer KK; Zhang B; Shrader JA; Peterson D; Smith M; Albert PS; Cutler GB
J Clin Endocrinol Metab; 2012 Feb; 97(2):391-9. PubMed ID: 22090268
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
Mannstadt M; Clarke BL; Bilezikian JP; Bone H; Denham D; Levine MA; Peacock M; Rothman J; Shoback DM; Warren ML; Watts NB; Lee HM; Sherry N; Vokes TJ
J Clin Endocrinol Metab; 2019 Nov; 104(11):5136-5147. PubMed ID: 31369089
[TBL] [Abstract][Full Text] [Related]
19. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy.
Cusano NE; Rubin MR; McMahon DJ; Irani D; Anderson L; Levy E; Bilezikian JP
J Clin Endocrinol Metab; 2014 Oct; 99(10):3694-9. PubMed ID: 24978675
[TBL] [Abstract][Full Text] [Related]
20. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
Winer KK; Yanovski JA; Cutler GB
JAMA; 1996 Aug; 276(8):631-6. PubMed ID: 8773636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
